Is this you? Create Your Porfile
Avatar

E. Aiello

Bristol-Myers Squibb

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where E. Aiello is active.

Explore More

Publication

Featured researches published by E. Aiello.

Value in Health | 2014

Dapagliflozin versus sulfonylurea as an add-on therapy to metformin: A cost-effectiveness analysis in Colombia

J.F. Elgart; M. Prestes; L. Gonzalez; P Aschner; S. Garrido Lecca; E. Aiello; C. Jimenez; Juan José Gagliardino

Value in Health | 2014

Saxagliptin/metformin extended-release (XR) for the type 2 diabetes (T2DM) treatment in venezuela: A budget impact analysis

J.F. Elgart; L. Gonzalez; A. Perez Monteverde; S. Garrido Lecca; E. Aiello; Juan José Gagliardino

European Heart Journal | 2013

Estimation of the effectiveness of apixaban in non valvular atrial fibrillation in anticoagulant suitable population in Argentina

Giorgi; C. Caroli; Paula Micone; N.D. Giglio; E. Aiello; B.M.K. Donato; J.F. Mould; G. Radero; M. Casas

Value in Health | 2011

PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American Countries

J.F. Elgart; J.E. Caporale; E. Aiello; M. Waschbusch; L. Jotimliansky; Juan José Gagliardino

Value in Health | 2014

Dapagliflozin: Cost-effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in Argentina and Chile

J.F. Elgart; M. Prestes; L. Gonzalez; S. Asteazaran; E. Aiello; S. Garrido Lecca; A. Alvarez; M. Roberts; P. Cortes Cuadra; Juan José Gagliardino

Value in Health | 2014

Treatment of type 2 diabetes in Colombia: Economic evaluation of saxagliptin/metformin extended-release (XR) fixed-dose combination (FDC)

J.F. Elgart; M. Prestes; L. Gonzalez; S. Garrido Lecca; E. Aiello; C. Jimenez; Juan José Gagliardino

Value in Health | 2013

Abatacept For The Treatment Of Patients With Rheumatoid Arthritis In Argentina: A Cost-Effectiveness Analysis

J.F. Elgart; L. Gonzalez; E. Aiello

Value in Health | 2013

Budget Impact Analysis Of The Introduction Of Saxagliptin/Metformin Extended-Release (Xr) In The Treatment Of Type-2 Diabetes In Chile

J.F. Elgart; Lorena González; E. Aiello; Juan José Gagliardino

Value in Health | 2013

Treatment of Type 2 Diabetes with Saxagliptin/Metformin Extended-Release (XR): Budget Impact Analysis in Argentina

J.F. Elgart; L. Gonzalez; E. Aiello; Juan José Gagliardino

Value in Health | 2013

Estimation of the Cost-Effectiveness of Apixaban in Non-Valvular Atrial Fibrillation in Argentina

M.A. Giorgi; C. Caroli; Paula Micone; N.D. Giglio; E. Aiello; B.M.K. Donato; J.F. Mould; G. Radero; M. Casas

Explore More

Collaboration

Dive into the E. Aiello's collaboration.

Top Co-Authors
Avatar

J.F. Elgart

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors
Avatar

Juan José Gagliardino

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors
Avatar

L. Gonzalez

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors
Avatar

B.M.K. Donato

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Carolina Zingoni

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

J.F. Mould

Pfizer

View shared research outputs
Top Co-Authors
Avatar

S. Garrido Lecca

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

M. Prestes

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors
Avatar

M. Waschbusch

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

J.E. Caporale

National Scientific and Technical Research Council

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge